FacebookTwitterGoogle+RedditEmail

The Withering of Big Pharma?

by MARTHA ROSENBERG

It used to be when a drug company settled illegal marketing charges that millions took its drugs under false pretenses, the news would be released on a Friday afternoon when no one would notice. That was then. Now almost all the drug companies have joined the Off label/Kickback club and the public doesn’t seem to notice or care.

On the surface, Johnson & Johnson’s $2.2 billion settlement this week for illegally marketing drugs to the elderly, children and the mentally disabled looks like a victory.  J&J’s subsidiary, Janssen Pharmaceuticals, will plead guilty to illegally promoting the antipsychotic Risperdal for “controlling aggression and anxiety in elderly dementia patients and treating behavioral disturbances in children and in individuals with disabilities,” reports Reuters. The promotions included a brazen kickback scheme to Omnicare Inc, a pharmacy supplying nursing homes, exposed by a whistleblower.

At least 15,000 elderly people in nursing homes die a year from drugs like Risperdal said FDA drug reviewer David Graham in Congressional testimony a few years ago. Eli Lilly who makes the similar drug Zyprexa and AstraZeneca who makes Seroquel have also settled charges that they churned the elderly drug market at the price of Grandma and Grandpa’s lives.

But it is not a victory. J&J made $24.2 billion off Risperdal from 2003 to 2010 and shareholders won’t even notice this week’s nano loss. J&J milked Risperdal for all it was worth and the patent had already run out by the time it was charged with illegal schemes. Other drug giants charged with illegal marketing schemes–Abbott for Depakote, Pfizer for Bextra,  Eli Lilly for Zyprexa, AstraZeneca for Seroquel, GlaxoSmithKline for Paxil and Merck for Vioxx–also got their money’s worth before the trivial nuisance of suit. Many, like Pfizer who illegally marketed its seizure drug Neurontin while under probation for illegal Lipitor activities–are brazen and shameless repeat offenders.

Many say the only justice that will get Big Pharma’s attention is frog marching the CEOs off to prison and/or cutting them off from their lucrative public trough of Medicare, Medicaid and military health programs.

Still, Big Pharma’s audacious business plan of asking forgiveness not permission is winding down. Not because Pharma, prescribers, consumers, regulators and health officials have seen the light but because there are no more big drugs to pimp. An estimated 100,000 workers will be losing their jobs at Pfizer, Sanofi, Roche, GlaxoSmithKline, AstraZeneca and Merck reported Yahoo finance last month.

Only two new drug campaigns seem to be brewing and they require a major suspension of reality on the part of doctors and patients. One tries to convince people with low back pain they actually suffer from ankylosing spondylitis an arthritis-like condition that causes chronic inflammation of the spine.  If your spine is stiff when you wake up in the morning you can take an immune suppressor like Humira which puts you at risk of tuberculosis and lethal viral, fungal and bacterial infections while costing you $12,000 to $17,000 a year. Line forms to the left.

The other, even more brazen campaign, tries to convince people with insomnia, tiredness during the day, moodiness and relationship problems that they actually suffer from Non-24-Hour Sleep–Wake Disorder, a disorder that affects mostly blind people. You don’t have to be blind to have the disorder, says the new Pharma message even though there have been fewer than 100 cases of sighted people with non-24 reported in the scientific literature. It sounds like a stretch but so did convincing people with job, money and marriage problems they really had depression or bipolar disorder.

Still it is obvious the bloom has fallen off the Big Pharma rose and it is now paying the piper for the high-flying party with drug settlements like Johnson & Johnson’s this week. But that doesn’t mean shady marketing, hidden risks, kickbacks and outrageous prices are gone from the medical field. They have just moved to the Medical Device industry.

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

 

 

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

July 20, 2017
Sebastian Friedrich – Gabriel Kuhn
A New Class Politics
Patrick Cockburn
The Massacre of Mosul: More Than 40,000 Civilians Feared Dead
Paul Street
The Abandonment: Reflections on James Foreman’s “Locking Up Our Own”
Kim Codella
A Practical Education
Frank Scott
America’s Trump, Not Trump’s America
Louis Proyect
Clancy Sigal Goes Away
Don Monkerud
The Real Treason in DC: Turning Our Lives Over to Corporate
Brian Dew – Dean Baker
Are Amazon’s Shareholders Suckers?
Ralph Nader
Detecting What Unravels Our Society – Bottom-up and Top-down
Barbara Nimri Aziz
Covering Islam, Post-Jack Shaheen
Binoy Kampmark
Uhlmann’s Trump Problem
Patrick Walker
In Defense of Caitlin Johnstone
Barry Lando
Those Secret Putin-Trump Talks
Sean Marquis
Thank You, Donald Trump
July 19, 2017
Adam Ziemkowski and Rebekah Liebermann
How Seattle Voted to Tax the Rich
Patrick Cockburn
Why ISIS Fighters are Being Thrown Off Buildings in Mosul
John W. Whitehead
Zombies R Us: the Walking Dead of the American Police State
Mateo Pimentel
Net Neutrality’s Missing Persons
Adil E. Shamoo - Bonnie Bricker
Yemen Policy is Creating More Terrorists
L. Ali Khan
U.S. Misreads Pakistan’s Antifragility
David Macaray
Fear and Trembling in the Workplace
Brian Trautman, Gerry Condon and Samantha Ferguson
Veterans Call on U.S. to Sign Nuclear Ban Treaty
Binoy Kampmark
Militarising Civilian Life: Australia, Policing and Terrorism
Ricardo Vaz
Venezuelan Opposition “Consultation”: Playing Alone and Losing
Jesse Jackson
Trump’s Cold-Hearted Agenda is Immoral
Raul Castro
We will Continue to Advance Along the Path Freely Chosen by Our People
July 18, 2017
James Bovard
Obama’s AWOL Anti-War Protesters
Gary Leupp
CNN: “Russia is an Adversary, Ukraine is Not.”
Ryan Shah
Beware the Radical Center
John Carroll Md
Cold Hands Don’t Need Narcotics
Derrick Jensen
Endangered Species Don’t Need an Ark – They Need a Living Planet!
Kenneth Surin
Brief Impressions of the Canadian Conjucture
Arturo Lopez-Levy
Trump’s Cuba Restrictions: a Detour, Not the Future
Russell Mokhiber
State Street Bentley University Business Ethics and Corporate Crime
Laura Finley
Being Too Much
Robert J. Gould
What is Our Experience of our Flawed Democracy?
Taju Tijani
The Burden of Indivisible Nigeria
Guillaume Pitron
China Now Leads in Renewables
Ted Rall
How I Learned Courts are Off-Limits to the 99 Percent
Binoy Kampmark
Militarising Civilian Life: Australia, Policing and Terrorism
July 17, 2017
Gregory Wilpert
Time for the “International Left” to Take a Stand on Venezuela
Gary Leupp
Trump’s Embrace of the Saudi Crown Prince, and a Qatar Nightmare Scenario
Thomas Hon Wing Polin
Liu Xiaobo: the West’s Model Chinese
Terry Simons
Why I Did Not Go to Vietnam
Jim Green
Nuclear Power’s Annus Horribilus
FacebookTwitterGoogle+RedditEmail